{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-002774","form_type":"8-K","ticker":"UFPT","cik":"0000914156","company_name":"UFP TECHNOLOGIES INC","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.782863+00:00","generated_at":"2026-06-16T04:26:49.450619+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"UFP Technologies Q1 net income $9.7M ($1.27 EPS), revenue up 37% to $97.8M","bullets":["Medical market sales surged 59.5% to $83.8M, led by 112% growth in robotic surgery.","Gross margin improved 530 bps to 29.4% from 24.1% a year ago, boosting profitability.","Operating income rose 101.9% to $12.8M; adjusted operating income up 120.3% to $15.7M.","EBITDA grew 64.8% to $15.5M; adjusted EBITDA jumped 78.7% to $19.5M.","Company absorbed $2.85M contingent consideration charge for DAS acquisition, reflects strong performance."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-002774","json":"https://secwatch.observer/filing/0001171843-23-002774.json","markdown":"https://secwatch.observer/filing/0001171843-23-002774.md","text":"https://secwatch.observer/filing/0001171843-23-002774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914156/000117184323002774/0001171843-23-002774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914156/000117184323002774/f8k_050223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T04:26:49.450619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38ccb81ce182a33b40301bae08cfc4505c2a3fc6","claim":"UFP TECHNOLOGIES INC reported first quarter ended March 31, 2023 results: revenue $97.8 million, net income $9.7 million, EPS $1.27 per diluted common share.","evidence_excerpt":"UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $9.7 million or $1.27 per diluted common share outstanding for its first quarter ended March 31, 2023, compared to net income of $4.9 million or $0.64 per diluted common share outstanding for the first quarter of 2022. Net Sales for the first quarter were $97.8 million compared to 2022 first quarter sales of $71.2 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914156/000117184323002774/0001171843-23-002774-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$97.8 million"},{"label":"Net income","value":"$9.7 million"},{"label":"EPS","value":"$1.27 per diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}